Tag(s):
Australian court rules on Baxter fine
Premium Article - Thursday, 26 August 2010
The Federal Court of Australia today fined pharmaceuticals company Baxter Healthcare A$4.9 million (€3.4 million) for anti-competitive practices in the sale of medical supplies.
CSL and Baxter hit with twin antitrust suits
Premium Article - Monday, 24 August 2009
US health-care provider Solaris Health Systems has filed a proposed antitrust class action alleging biotherapeutics companies CSL and Baxter International conspired to fix the price of life-saving blood plasma treatments.



